NCT03114319 2026-04-16
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Phase 1 Terminated
Novartis
Royal Marsden NHS Foundation Trust
University of Chicago
University of Erlangen-Nürnberg Medical School
Sotio Biotech Inc.